HomeERNA • NASDAQ
add
Ernexa Therapeutics Inc
Previous close
$0.18
Day range
$0.17 - $0.19
Year range
$0.15 - $2.63
Market cap
11.17M USD
Avg Volume
358.42K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.73M | -52.71% |
Net income | -8.20M | -23.39% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.71M | 52.82% |
Effective tax rate | -0.10% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.92M | -62.51% |
Total assets | 5.06M | -89.81% |
Total liabilities | 11.01M | -79.26% |
Total equity | -5.95M | — |
Shares outstanding | 62.36M | — |
Price to book | -1.65 | — |
Return on assets | -132.16% | — |
Return on capital | 1,998.54% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -8.20M | -23.39% |
Cash from operations | -2.06M | 44.89% |
Cash from investing | — | — |
Cash from financing | 2.25M | 62.74% |
Net change in cash | 189.00K | 107.69% |
Free cash flow | 4.44M | 410.81% |
About
Founded
2018
Headquarters
Website
Employees
6
